Search results
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its
AVTR vs. ICLR: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Avantor, Inc. (AVTR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook
Avantor, Inc. (AVTR) Beats Q2 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.24 per share a year ago. These
Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended June 2026, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, up 0.5% over the same period last year. EPS came in at $0.21, compared to $0.24 in the year-ago quarter.
The
Avnet to Post Q4 Earnings: Time to Buy, Sell or Hold the Stock?
Avnet AVT is scheduled to report fourth-quarter fiscal 2026 results on Aug. 5, before market open.
For the fourth quarter of fiscal 2026, AVT expects adjusted earnings per share between $1.70 and
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership
Avantor AVTR recently announced that its NuSil brand has expanded the long-standing collaboration with the Population Council to support the development of a next-generation three-month dapivirine
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Avantor, Inc
Can Margin Expansion Sustain Avnet's Earnings Growth in FY26?
Avnet's AVT profitability continued to improve in the third quarter of fiscal 2026, even as gross margins remained under pressure, highlighting the benefits of disciplined cost management and
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
Avantor, Inc. AVTR reported second-quarter 2026 adjusted earnings per share (EPS) of 21 cents, down 12.5% from the year-ago quarter. However, the bottom line surpassed the Zacks Consensus Estimate



